• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRACCO INJENEERING SA EMPOWER CTA+; INJECTOR, CONTRAST MEDIUM, AUTOMATIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRACCO INJENEERING SA EMPOWER CTA+; INJECTOR, CONTRAST MEDIUM, AUTOMATIC Back to Search Results
Model Number EMPOWER CTA+
Device Problem Use of Device Problem (1670)
Patient Problem Air Embolism (1697)
Event Date 08/21/2020
Event Type  Injury  
Manufacturer Narrative
Review of the device history record of the empower cta+ injector, serial number (b)(4), was completed and there were no deviations noted.The instructions for use have been reviewed and no inadequacies were identified regarding warnings, contraindications, and the directions/conditions for the use of the device.Per information provided by the user facility, there was no indication of a device malfunction.The empower cta+ injector and associated consumable kits have been requested to be sent to the acist medical systems, inc.Service center for investigation.The devices have not been received by acist at the time of this report.A follow-up report will be submitted to fda upon completion of additional investigation.
 
Event Description
User facility reported that during an abdominopelvic computed tomography procedure using the empower cta+ injector, air was injected into the patient.No medical history, concomitant medications, allergies or prior use of contrast was reported.The ct procedure was completed by a retention nurse and was the last ct procedure the retention nurse performed that evening.Post the air injection, the patient had a stroke.The patient has been discharged from the hospital and has recovered; date of discharge not provided.The hospital safety committee spoke with the nurse and they have not been able to define what happened, but the suspected cause was user error.
 
Manufacturer Narrative
No evidence of device malfunction related to the reported event based on review of the device history records and information provided by the user facility.Although requested, the user facility elected not to return the injector system to acist for investigation and the consumables were discarded by the user facility.No additional information received on the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMPOWER CTA+
Type of Device
INJECTOR, CONTRAST MEDIUM, AUTOMATIC
Manufacturer (Section D)
BRACCO INJENEERING SA
46 avenue de sévelin
lausanne, vd 1004
SZ  1004
MDR Report Key10578186
MDR Text Key208302898
Report Number3004753774-2020-00001
Device Sequence Number1
Product Code IZQ
Combination Product (y/n)N
PMA/PMN Number
K071378
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEMPOWER CTA+
Device Catalogue Number017285
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-